Stryker Co. (NYSE:SYK) Shares Acquired by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC lifted its holdings in shares of Stryker Co. (NYSE:SYK) by 21.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 124,596 shares of the medical technology company’s stock after acquiring an additional 21,801 shares during the period. Nisa Investment Advisors LLC’s holdings in Stryker were worth $44,965,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the business. AE Wealth Management LLC grew its position in shares of Stryker by 101.8% in the 2nd quarter. AE Wealth Management LLC now owns 3,414 shares of the medical technology company’s stock valued at $1,162,000 after buying an additional 1,722 shares during the last quarter. Pacer Advisors Inc. grew its holdings in shares of Stryker by 8.4% during the second quarter. Pacer Advisors Inc. now owns 27,438 shares of the medical technology company’s stock worth $9,336,000 after purchasing an additional 2,122 shares during the last quarter. Thrivent Financial for Lutherans increased its position in shares of Stryker by 69.7% during the second quarter. Thrivent Financial for Lutherans now owns 87,244 shares of the medical technology company’s stock worth $29,685,000 after purchasing an additional 35,833 shares in the last quarter. ProShare Advisors LLC lifted its holdings in shares of Stryker by 6.6% in the 2nd quarter. ProShare Advisors LLC now owns 51,470 shares of the medical technology company’s stock valued at $17,513,000 after purchasing an additional 3,206 shares during the last quarter. Finally, Epoch Investment Partners Inc. boosted its position in shares of Stryker by 1.6% in the 2nd quarter. Epoch Investment Partners Inc. now owns 4,276 shares of the medical technology company’s stock valued at $1,455,000 after purchasing an additional 68 shares during the period. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have commented on SYK shares. BTIG Research lifted their price target on Stryker from $383.00 to $394.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Barclays lifted their target price on shares of Stryker from $402.00 to $418.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. Wells Fargo & Company increased their price target on shares of Stryker from $405.00 to $427.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 11th. UBS Group lifted their price objective on shares of Stryker from $366.00 to $370.00 and gave the company a “neutral” rating in a research note on Wednesday, October 30th. Finally, Truist Financial increased their target price on shares of Stryker from $380.00 to $409.00 and gave the stock a “hold” rating in a research note on Wednesday, December 18th. Five research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $405.80.

Insider Transactions at Stryker

In other Stryker news, CEO Kevin Lobo sold 57,313 shares of the business’s stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $368.70, for a total value of $21,131,303.10. Following the completion of the transaction, the chief executive officer now directly owns 100,027 shares in the company, valued at approximately $36,879,954.90. The trade was a 36.43 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 5.50% of the company’s stock.

Stryker Stock Up 3.2 %

SYK opened at $395.86 on Wednesday. Stryker Co. has a one year low of $307.23 and a one year high of $398.20. The company has a market cap of $150.91 billion, a price-to-earnings ratio of 42.43, a PEG ratio of 2.63 and a beta of 0.95. The business’s fifty day moving average is $375.61 and its two-hundred day moving average is $359.53. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.22 and a current ratio of 1.91.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Tuesday, October 29th. The medical technology company reported $2.87 EPS for the quarter, beating analysts’ consensus estimates of $2.77 by $0.10. The firm had revenue of $5.49 billion for the quarter, compared to analysts’ expectations of $5.37 billion. Stryker had a net margin of 16.34% and a return on equity of 23.07%. The firm’s revenue was up 11.9% on a year-over-year basis. During the same period in the prior year, the company earned $2.46 EPS. Analysts anticipate that Stryker Co. will post 12.06 EPS for the current fiscal year.

Stryker Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.84 per share. This is an increase from Stryker’s previous quarterly dividend of $0.80. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.36 annualized dividend and a yield of 0.85%. Stryker’s dividend payout ratio (DPR) is presently 36.01%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.